Search
for
Sort by
Research 811–840 of 1000+
- Maintenance, withdrawal, and re-treatment with ritlecitinib and brepocitinib in patients with alopecia areata in a single-blind extension of a phase 2a randomized clinical trial
- Selective Janus kinase 1 inhibition resolves inflammation and restores hair growth offering a viable treatment option for alopecia areata
- Switching between tofacitinib and baricitinib in alopecia areata: A review of clinical response
- Exploring the Use of Topical Tofacitinib in Pediatric Alopecia Totalis
- Comparative Efficacy and Safety of Baricitinib Against Traditional Therapies in Severe Alopecia Areata: A Retrospective Cohort Study
- Age-associated inflammation inhibits epidermal stem cell function
- Calcineurin/Nfatc1 signaling links skin stem cell quiescence to hormonal signaling during pregnancy and lactation
- Poster Presentations
- Alopecia universalis unresponsive to treatment with tofacinitib: report of a case with a brief review of the literature
- Efficacy and Potential Mechanisms of Naringin in Atopic Dermatitis
- Myeloproliferative disorder associated with alopecia universalis
- Topical metformin as a novel therapy for alopecia areata due to its immunologic effects
- Exploring the potential of natural products in treating alopecia areata
- Ruxolitinib found to cause eyelash growth: a case report
- Efficacy and Safety of Switching from Baricitinib to Ritlecitinib in Severe Alopecia Areata
- Upadacitinib for Alopecia Areata in Different Backgrounds: A Case Series
- INVESTIGATING THE MECHANISMS UNDERLYING THE PATHOGENESIS OF ALOPECIA AREATA
- A pilot study of 2% tofacitinib cream with narrowband ultraviolet B for the treatment of facial vitiligo
- USE OF UPADACITINIB IN 2 CASES OF REFRACTORY SYSTEMIC LUPUS ERYTHEMATOSUS
- Upadacitinib for the Management of Alopecia Totalis and Subtotalis in Pediatric Patients: A Case Series
- Treatment of anti-MDA5 autoantibody-positive juvenile dermatomyositis using tofacitinib
- Acral Vitiligo: A Comprehensive Review of Clinical Features, Pathogenesis, and Novel Therapeutic Advances
- Epigallocatechin-3 Gallate Inhibits STAT-1/JAK2/IRF-1/HLA-DR/HLA-B and Reduces CD8 MKG2D Lymphocytes of Alopecia Areata Patients
- A new era for alopecia areata: New treatments and improved knowledge of the condition
- TGF-β Signaling: a Potential Therapeutic Target of Single Herbs and Extracts for Renal Fibrosis
- 455 Beyond Immunity: TEC and JAK3 Kinase Activation in Melanocytes Drives Inflammation in Vitiligo
- Case report: Psoriasiform eczema with immune-mediated comorbidities treated with upadacitinib
- Effectiveness and safety of baricitinib in severe alopecia areata: 48‐week results
- Tofacitinib in the Management of Alopecia Universalis
- Central nervous system demyelination associated with tofacitinib use in alopecia areata: A case report and literature review